Coloplast CEO to invest in emerging markets: "Our business should be three times larger"

Coloplast CEO Kristian Villumsen wants to grow faster, and more in rapidly developing markets like China, India and Russia, although the company is already doing well. The growth is to mitigate the impact of the reimbursement reform in France.

Photo: Mads Nissen/STF/Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles